Cytotoxic Activities and Molecular Mechanisms of the Beauvericin and Beauvericin G1 Microbial Products against Melanoma Cells

Many ways to resistance: How melanoma cells evade targeted therapies

(2019) Ines Kozar et al.   BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER

Cancer treatment and survivorship statistics, 2019

(2019) Kimberly D. Miller et al.   CA-A CANCER JOURNAL FOR CLINICIANS

In vitro mechanisms of Beauvericin toxicity: A review

(2018) Beatriz Mallebrera et al.   FOOD AND CHEMICAL TOXICOLOGY

Structural Diversity and Biological Activities of Cyclic Depsipeptides from Fungi

(2018) Xiaohan Wang et al.   MOLECULES

Natural Cyclic Peptides as an Attractive Modality for Therapeutics: A Mini Review

(2018) Muna Abdalla et al.   MOLECULES

Beauvericin inhibits melanogenesis by regulating cAMP/PKA/CREB and LXR-α/p38 MAPK–mediated pathways

(2018) Seung Eun Lee et al.   Scientific Reports

A Review on the Synthesis and Bioactivity Aspects of Beauvericin, a Fusarium Mycotoxin

(2018) Qinghua Wu et al.   Frontiers in Pharmacology

A natural product-like JAK2/STAT3 inhibitor induces apoptosis of malignant melanoma cells

(2017) Ke-Jia Wu et al.   PLoS One

Targeting the PI3K/AKT/mTOR pathway overcomes the stimulating effect of dabrafenib on the invasive behavior of melanoma cells with acquired resistance to the BRAF inhibitor

(2016) Simona Caporali et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?

(2016) S Baig et al.   Cell Death & Disease

Systematic analysis of BRAFV600E melanomas reveals a role for JNK/c-Jun pathway in adaptive resistance to drug-induced apoptosis

(2015) M. Fallahi-Sichani et al.   Molecular Systems Biology

Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy

(2015) Anna Niezgoda et al.   Biomed Research International

Multiple Molecular Pathways in Melanomagenesis: Characterization of Therapeutic Targets

(2015) Giuseppe Palmieri et al.   Frontiers in Oncology

Pathways and therapeutic targets in melanoma

(2015) Emma Shtivelman et al.   Oncotarget

Cyclodepsipeptides: A Rich Source of Biologically Active Compounds for Drug Research

(2014) Sivatharushan Sivanathan et al.   MOLECULES

Review of Natural Compounds for Potential Skin Cancer Treatment

(2014) Tawona Chinembiri et al.   MOLECULES

The potential for targeting the STAT3 pathway as a novel therapy for melanoma

(2013) Gregory B Lesinski   Future Oncology

The Role of the PI3K-AKT Pathway in Melanoma

(2012) Michael A. Davies   CANCER JOURNAL

Melanoma: from mutations to medicine

(2012) H. Tsao et al.   GENES & DEVELOPMENT

NF-κB as potential target in the treatment of melanoma

(2012) Gabriele Madonna et al.   Journal of Translational Medicine

The role of BRAF V600 mutation in melanoma

(2012) Paolo A Ascierto et al.   Journal of Translational Medicine

Beauvericin, a Bioactive Compound Produced by Fungi: A Short Review

(2012) Qinggui Wang et al.   MOLECULES

Mitochondria in Apoptosis: Bcl-2 Family Members and Mitochondrial Dynamics

(2011) Jean-Claude Martinou et al.   DEVELOPMENTAL CELL